Showing results (601-610 of 804) with videos related to
Sort By:
Pageof 81
Journal of Alzheimer'S Disease Reports|October 15, 2026
Improving biomarkers of inflammation including phosphorylated tau in a patient with chronic Lyme disease/post-treatment Lyme disease syndrome using dapsone combination therapy: A case study and literature reviewRichard HorowitzJournal of Alzheimer'S Disease Reports|October 15, 2026
Feasibility of digital multidomain cognitive testing in mild cognitive impairment and dementia assessment in primary careWobbie Van den Hurk, Maria M Johansson, Elisabet Classon, et al.Journal of Alzheimer'S Disease Reports|October 28, 2026
Perspectives on plasma biomarkers for point-of-care diagnostics in Alzheimer's disease: Insights into 2D-BioPADAngeliki Koukoura, Kyriaki Antonopoulou, Apostolos C Tsolakis, et al.Journal of Alzheimer'S Disease Reports|December 6, 2021
Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer's Disease and Frontotemporal DementiaYi Jayne Tan, Benjamin Y X Wong, Ramanathan Vaidyanathan, et al.Journal of Alzheimer'S Disease Reports|January 28, 2022
A Non-Invasive Determination of Ketosis-Induced Elimination of Chronic Daytime Somnolence in a Patient with Late-Stage Dementia (Assessed with Type 3 Diabetes): A Potential Role of NeurogenesisLeslie A Lewis, Carl M Urban, Sami A HashimJournal of Alzheimer'S Disease Reports|January 28, 2022
A Novel Intervention for Management of Behavioral and Psychological Symptoms of Dementia in Nursing Home Communal Areas: Results of a Small-Scale Pilot TrialGloria Gutman, Avantika Vashisht, Taranjot Kaur, et al.Journal of Alzheimer'S Disease Reports|January 28, 2022
Is There Any Evidence of Monocytes Involvement in Alzheimer's Disease? A Pilot Study on Human Postmortem BrainCamelia-Maria Monoranu, Tim Hartmann, Sabrina Strobel, et al.Journal of Alzheimer'S Disease Reports|October 11, 2021
Reaction Time Decomposition as a Tool to Study Subcortical Ischemic Vascular Cognitive ImpairmentEmma Richards, Andrea Tales, Antony Bayer, et al.Journal of Alzheimer'S Disease Reports|April 1, 2022
Salivary Proteomics Identifies Transthyretin as a Biomarker of Early Dementia ConversionEce Eldem, Aatmika Barve, Olivier Sallin, et al.Journal of Alzheimer'S Disease Reports|March 4, 2022
Robust Pharmacodynamic Effect of LY3202626, a Central Nervous System Penetrant, Low Dose BACE1 Inhibitor, in Humans and Nonclinical SpeciesBrian A Willis, Stephen L Lowe, Scott A Monk, et al.Pageof 81